1. Home
  2. CBAT vs BEAT Comparison

CBAT vs BEAT Comparison

Compare CBAT & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBAK Energy Technology Inc.

CBAT

CBAK Energy Technology Inc.

HOLD

Current Price

$1.04

Market Cap

71.5M

Sector

Miscellaneous

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$1.49

Market Cap

58.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAT
BEAT
Founded
1999
2015
Country
China
United States
Employees
N/A
16
Industry
Industrial Machinery/Components
Retail: Computer Software & Peripheral Equipment
Sector
Miscellaneous
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
71.5M
58.6M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
CBAT
BEAT
Price
$1.04
$1.49
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.75
AVG Volume (30 Days)
228.1K
383.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
533.33
N/A
EPS
N/A
N/A
Revenue
$176,614,609.00
N/A
Revenue This Year
$16.06
N/A
Revenue Next Year
$70.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.54
52 Week High
$1.25
$4.00

Technical Indicators

Market Signals
Indicator
CBAT
BEAT
Relative Strength Index (RSI) 63.65 43.28
Support Level $0.83 $1.33
Resistance Level $1.06 $1.82
Average True Range (ATR) 0.07 0.10
MACD 0.01 0.04
Stochastic Oscillator 82.64 58.97

Price Performance

Historical Comparison
CBAT
BEAT

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: